The strong institutional accumulation, especially by BlackRock and Geode, combined with a $17.7M insider buy, signals high conviction in ARTV's pipeline or upcoming catalyst. However, the 45-day 13F reporting lag means these positions may already be stale. Monitor for any pipeline updates (clinical trial data, FDA interactions) that could justify this buildup. The historical positive drift on ARTV reports (+21% T+20 avg) suggests momentum may persist, but the passive-heavy nature of the buying means the stock could be vulnerable to macro-driven index rebalancing.
Executive Summary
A strong institutional cluster formed in ARTV during 2026-Q2, with 6 mega-passive and asset-manager buyers accumulating $9.9M in net new holdings, overwhelmingly dominated by BlackRock ($5.4M added) and Geode ($2.8M added). The sole seller, Morgan Stanley, exited nearly completely. This buying coincides with a single open-market insider purchase of $17.7M, creating a rare confluence of institutional and insider conviction. The cluster is almost entirely passive/index-driven, which slightly tempers the signal, but the sheer scale and unanimity of the accumulation is notable for a small-cap biotech. The historical calibration shows strong positive drift on prior ARTV reports (+21% avg T+20 return), supporting a bullish read, though the score-7 observed win rate is only 43-48%, warranting a modest score adjustment downward from the raw cluster strength.
Key Financial Metrics
Institutional Positions
Net institutional flow: $9.9M
▲ Buyers (6)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| BlackRock | DOUBLED | +225.6% | $6.7M | $5.4M |
| Geode | DOUBLED | +247.9% | $3.4M | $2.8M |
| State Street | DOUBLED | +362.7% | $1.6M | $1.4M |
| Dimensional Fund Advisors | DOUBLED | +120% | $435.0K | $304.0K |
| Goldman Sachs | ADD | +37.6% | $153.0K | $79.0K |
| JPMorgan | DOUBLED | +1779.4% | $40.0K | $39.0K |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | NEAR_EXIT | -86.5% | $105.0K | -$84.0K |
Key Facts
- 6 institutional buyers vs 1 seller in 2026-Q2
- Net institutional inflow of $9.9M into ARTV
- BlackRock doubled its position to $6.7M (largest buyer)
- Geode doubled to $3.4M; State Street quadrupled to $1.6M
- Morgan Stanley nearly exited (-86.5% of shares)
- Concurrent insider open-market buying of $17.7M (1 buyer)
- Cluster dominated by mega-passive managers (BlackRock, Geode, State Street, JPMorgan, Goldman Sachs)
Financial Impact
6 institutions accumulated $9.9M in net new ARTV holdings during Q2 2026, while 1 seller reduced by $84K. Total institutional holdings in the cluster rose to $12.4M.
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound
- Cluster is dominated by passive/index funds, not active managers with alpha
- Small-cap biotech with limited float — high volatility risk
- Score-7 historical win rate is only 43-48% in this segment, suggesting potential over-optimism
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ARTV-2026-Q2 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 20d ago | 8-K | $10.14 $8.91 | ▼ −12.13% | ▼ −11.67% | — |
Sep 9, 2026 23d ago | Insider Cluster | $10.79 $10.42 | ▼ −3.43% | ▼ −2.83% | — |
Sep 9, 2026 23d ago | Insider Cluster | $10.79 $10.42 | ▼ −3.43% | ▼ −2.83% | — |
Sep 9, 2026 23d ago | Insider Cluster | $10.79 $10.42 | ▼ −3.43% | ▼ −2.83% | — |
Sep 9, 2026 23d ago | Insider Cluster | $10.79 $10.42 | ▼ −3.43% | ▼ −2.83% | — |
Sep 9, 2026 23d ago | Insider Cluster | $10.79 $10.42 | ▲ +3.43% | ▲ +2.83% | — |
Sep 4, 2026 28d ago | Insider Cluster | $11.19 $10.88 | ▼ −2.77% | ▼ −2.22% | — |
Aug 15, 2026 6w ago | Institutional Cluster | $11.74 $11.68 | ▼ −0.51% | ▲ +0.16% | — |
Jul 31, 2026 8w ago | Insider Buy | $10.76 $11.07 | ▲ +2.88% | ▲ +1.08% | — |
Jul 28, 2026 9w ago | Insider Buy | $10.53 $10.02 | ▼ −4.84% | ▼ −3.30% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access